News Detail - Eckert & Ziegler Strahlen- und Medizintechnik AG

Eckert & Ziegler resolves capital increase


ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Capital Increase
Release of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

Berlin, 12th January 2009. – The Board of Directors at Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE 0005659700) has resolved today with the consent of the Supervisory Board to implement a capital increase for cash with a partial utilisation of the approved capital in volumes of up to 628,633 new shares. With the expected funds inflow parts of the purchase price and the net current assets are to be financed in connection with the acquisition of a competitor. As announced on 22 December 2008 Eckert & Ziegler acquired the buyer’s option.

The shareholders of the company will be granted a purchase right. Trading the purchase rights via the stock exchange is not possible. The new shares will not be permitted to be traded on the regulated market until further notice so that no stock market trading will take place. The company intends to effect the listing of the new shares at a later date. Linked to this is the prior establishment and approval of a securities prospectus according to the regulations of the Securities Prospectus Act. BankM, representation of biw Bank für Investments und Wertpapiere AG, has been commissioned with monitoring the capital increase.



Information and Explaination of the Issuer to this News:
An interview with the Chairman of the Board, Dr. Andreas Eckert, on the topic of capital increase will be published at www.ezag.de.
Eckert & Ziegler AG, Karolin Riehle, Investor Relations Robert-Rössle-Str. 10, D-13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, Fax –112
E-Mail: karolin.riehle@ezag.de, www.ezag.de


12.01.2009  Financial News transmitted by DGAP

 
Language:     English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG               Robert-Rössle-Str. 10
              13125 Berlin
              Deutschland
Phone:        +49 (0)30 941 084-0
Fax:          +49 (0)30 941 084-112
E-mail:       karolin.riehle@ezag.de
Internet:     www.ezag.de
ISIN:         DE0005659700
WKN:          565970
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, München, Hamburg, Düsseldorf  
End of News DGAP News-Service